Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

View All Favorites

A library of resources for the prevention,
management, and elimination of TB.

Filter your results

Clear All Filters

Showing 1 - 4 of 4 Results

Number of items to view

Filter Your Results

Title	Year
Trends in Tuberculosis – United States, 2013 This report summarizes provisional TB surveillance data reported to CDC in 2013. Case counts and incidence rates continue to decline, but certain groups are disproportionately affected. TB incidence rate among foreign-born persons in 2013 was approximately 13 times greater than the rate among US born persons and the proportion of TB cases among foreign born persons increased to 64... Researchers	2014
MMWR: Implementation of New TB Screening Requirements for U.S.-Bound Immigrants and Refugees–2007-2014 This report summarizes worldwide implementation of new TB screening requirements for foreign-born persons applying for either an immigrant visa or refugee status to enter the United States. In 2007 CDC issued Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy (CDOT TB TI)... Researchers	2014
MMWR: Trends in Tuberculosis – United States, 2012 This report summarizes provisional TB surveillance data reported to CDC’s National Tuberculosis Surveillance System in 2012. A total of 9,951 new TB cases were reported for an incidence of 3.2 cases per 100,000 population, which is a decrease of 6.1 percent from the incidence in 2011. TB incidence rate among foreign-born persons in the United States was 11... Researchers	2013
MMWR: Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis This report provides provisional CDC guidelines for FDA-approved and unapproved, or off-label, uses of bedaquiline in certain populations who were not included in the clinical trials for the drug. These guidelines are intended for health-care professionals who might use bedaquiline for the treatment of MDR TB for indicated and off-label uses... Researchers	2013